ArticleBioengineering (Basel, Switzerland)2025
CoviSwin: A Deep Vision Transformer for Automatic Segmentation of COVID-19 CT Scans.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Energy Measures as Biomarkers of SARS-CoV-2 Variants and Receptors.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Precise segmentation of COVID-19 lesions in chest Computed Tomography (CT) scans can directly impact patient care, yet existing methods struggle, when undertaking this task, with the heterogeneous appearance of ground-glass opacities, consolidations, and the availability of limited labeled data. We propose herein CoviSwin, a Transformer-based U-shaped encoder-decoder network that combines the Large model of Swin Transformer Version 2 with attention and residual connections to capture both global context and fine details. A two-phase training strategy is applied whereby in the first phase the encoder is initially frozen while training the decoder on the public SemiSeg dataset, then in the second phase, the encoder is partially unfrozen while the whole model is trained on the publicly available MedSeg dataset. The model achieves a ten-run mean sensitivity value of 0.790 ± 0.012, an average Dice Similarity Coefficient (DSC) score of 0.781 ± 0.0068, and an average specificity of 0.962 ± 0.0049, outperforming the sensitivity results obtained by recent models such as NextSeg of 2024 and GFNet of 2022 by 8.07% and 7.48%, respectively. These findings demonstrate the potential of CoviSwin as an effective model for clinical COVID-19 lesion segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.